(Health News) December 11 2006 – Research results released today by the National Cancer Institute indentify a new approach that may extend the effectiveness of Tamoxifen in preventing breast cancers and other estrogen sensitive cancers from reocurring.

The results were published today in the medical journal, Cancer Cell.

See the full article at http://health-news-now.com/blog/tamoxifen-breast-cancer-drug-enhanced-by-second-drug/68